Abrams J - Search Results

1

Phase II trial of 5 day continuous intravenous infusion of 6-thioguanine in patients with recurrent and metastatic squamous cell carcinoma of the head and neck.

Kruter F, Eisenberger M, Sinibaldi V, Engstrom C, Jacobs M, Abrams J, Belani C, Gray W, Krasnow S. Kruter F, et al. Among authors: abrams j. Invest New Drugs. 1992 Jul;10(2):89-91. doi: 10.1007/BF00873122. Invest New Drugs. 1992. PMID: 1500270 Clinical Trial.

2

A comparison of carboplatin plus methotrexate versus methotrexate alone in patients with recurrent and metastatic head and neck cancer.

Eisenberger M, Krasnow S, Ellenberg S, Silva H, Abrams J, Sinibaldi V, Van Echo D, Aisner J. Eisenberger M, et al. Among authors: abrams j. J Clin Oncol. 1989 Sep;7(9):1341-5. doi: 10.1200/JCO.1989.7.9.1341. J Clin Oncol. 1989. PMID: 2671289 Clinical Trial.

3

High-dose recombinant interleukin-2 alone: a regimen with limited activity in the treatment of advanced renal cell carcinoma.

Abrams JS, Rayner AA, Wiernik PH, Parkinson DR, Eisenberger M, Aronson FR, Gucalp R, Atkins MB, Hawkins MJ. Abrams JS, et al. J Natl Cancer Inst. 1990 Jul 18;82(14):1202-6. doi: 10.1093/jnci/82.14.1202. J Natl Cancer Inst. 1990. PMID: 2194036 Clinical Trial.

4

A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposide.

Belani CP, Egorin MJ, Abrams JS, Hiponia D, Eisenberger M, Aisner J, Van Echo DA. Belani CP, et al. Among authors: abrams js. J Clin Oncol. 1989 Dec;7(12):1896-902. doi: 10.1200/JCO.1989.7.12.1896. J Clin Oncol. 1989. PMID: 2555452

5

Phase II trial of N-methylformamide in advanced renal cancer.

Abrams JS, Tait N, Silva H, Eisenberger M, Van Echo DA, Olver IN, Aisner J. Abrams JS, et al. Am J Clin Oncol. 1989 Feb;12(1):41-2. doi: 10.1097/00000421-198902000-00009. Am J Clin Oncol. 1989. PMID: 2912020

6

Chemotherapy for prostatic carcinoma.

Eisenberger MA, Abrams JS. Eisenberger MA, et al. Among authors: abrams js. Semin Urol. 1988 Nov;6(4):303-10. Semin Urol. 1988. PMID: 3068768 Review. No abstract available.

7

How effective is cytotoxic chemotherapy for disseminated prostatic carcinoma?

Eisenberger MA, Kennedy P, Abrams J. Eisenberger MA, et al. Among authors: abrams j. Oncology (Williston Park). 1987 Jun;1(4):59-71. Oncology (Williston Park). 1987. PMID: 3079482 Review.

8

Immunomodulation of interleukin-2 by cyclophosphamide: a phase IB trial.

Abrams JS, Eiseman JL, Melink TJ, Sridhara R, Hiponia DJ, Bell MM, Belani CP, Adler WH, Aisner J. Abrams JS, et al. J Immunother Emphasis Tumor Immunol. 1993 Jul;14(1):56-64. doi: 10.1097/00002371-199307000-00008. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8399071 Clinical Trial.

9

A limited sampling strategy for cyclophosphamide pharmacokinetics.

Egorin MJ, Forrest A, Belani CP, Ratain MJ, Abrams JS, Van Echo DA. Egorin MJ, et al. Among authors: abrams js. Cancer Res. 1989 Jun 1;49(11):3129-33. Cancer Res. 1989. PMID: 2720671

10

Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.

Aisner J, Cirrincione C, Perloff M, Perry M, Budman D, Abrams J, Panasci L, Muss H, Citron M, Holland J, et al. Aisner J, et al. Among authors: abrams j. J Clin Oncol. 1995 Jun;13(6):1443-52. doi: 10.1200/JCO.1995.13.6.1443. J Clin Oncol. 1995. PMID: 7751891 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,261 results

Search Page

Filters